These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21586326)

  • 1. Production of recombinant peptides as fusions with SUMO.
    Satakarni M; Curtis R
    Protein Expr Purif; 2011 Aug; 78(2):113-9. PubMed ID: 21586326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of fermentation media and optimization of expression conditions for the production of EAK(16) peptide as fusions with SUMO.
    Satakarni M; Koutinas AA; Webb C; Curtis R
    Biotechnol Bioeng; 2009 Feb; 102(3):725-35. PubMed ID: 18973282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of an antitumor-analgesic peptide from the venom of Mesobuthus martensii Karsch by small ubiquitin-related modifier fusion in Escherichia coli.
    Cao P; Yu J; Lu W; Cai X; Wang Z; Gu Z; Zhang J; Ye T; Wang M
    Biotechnol Prog; 2010; 26(5):1240-4. PubMed ID: 20945481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli.
    Sun Z; Xia Z; Bi F; Liu JN
    Appl Microbiol Biotechnol; 2008 Mar; 78(3):495-502. PubMed ID: 18189135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.
    Zhang J; Ma L; Zhang SQ
    Protein Expr Purif; 2014 Mar; 95():177-81. PubMed ID: 24412409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner.
    Li JF; Zhang J; Song R; Zhang JX; Shen Y; Zhang SQ
    Appl Microbiol Biotechnol; 2009 Aug; 84(2):383-8. PubMed ID: 19582446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.
    Rao XC; Li S; Hu JC; Jin XL; Hu XM; Huang JJ; Chen ZJ; Zhu JM; Hu FQ
    Protein Expr Purif; 2004 Jul; 36(1):11-8. PubMed ID: 15177279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems.
    Panavas T; Sanders C; Butt TR
    Methods Mol Biol; 2009; 497():303-17. PubMed ID: 19107426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes.
    Peroutka Iii RJ; Orcutt SJ; Strickler JE; Butt TR
    Methods Mol Biol; 2011; 705():15-30. PubMed ID: 21125378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
    Sun Z; Lu W; Jiang A; Chen J; Tang F; Liu JN
    Protein Expr Purif; 2009 Jun; 65(2):238-43. PubMed ID: 19152836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO technology.
    Luan C; Zhang HW; Song DG; Xie YG; Feng J; Wang YZ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3651-58. PubMed ID: 24121930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture.
    Hoffmann A; Müller MQ; Gloser M; Sinz A; Rudolph R; Pfeifer S
    Protein Expr Purif; 2010 Aug; 72(2):238-43. PubMed ID: 20363332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
    Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
    Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.
    Marblestone JG; Edavettal SC; Lim Y; Lim P; Zuo X; Butt TR
    Protein Sci; 2006 Jan; 15(1):182-9. PubMed ID: 16322573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble expression and purification of the recombinant bioactive peptide precursor BPP-1 in Escherichia coli using a cELP-SUMO dual fusion system.
    Rao S; Zang X; Yang Z; Gao L; Yin Y; Fang W
    Protein Expr Purif; 2016 Feb; 118():113-9. PubMed ID: 26581779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO fusion facilitates expression and purification of garlic leaf lectin but modifies some of its properties.
    Upadhyay SK; Saurabh S; Rai P; Singh R; Chandrashekar K; Verma PC; Singh PK; Tuli R
    J Biotechnol; 2010 Mar; 146(1-2):1-8. PubMed ID: 20100526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO as a solubility tag and in vivo cleavage of SUMO fusion proteins with Ulp1.
    Kuo D; Nie M; Courey AJ
    Methods Mol Biol; 2014; 1177():71-80. PubMed ID: 24943315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology.
    Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G
    Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esterase 2 from Alicyclobacillus acidocaldarius as a reporter and affinity tag for expression and single step purification of polypeptides.
    Huang Y; Humenik M; Sprinzl M
    Protein Expr Purif; 2007 Jul; 54(1):94-100. PubMed ID: 17399994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.